Q BioMed, Inc. (OTC: QBIO) is a biomedical acceleration and development company focused on acquiring companies and biomedical assets. Q BioMed is dedicated to providing these target companies and assets, strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need‏. The company is assessing multiple biomedical assets in various areas of healthcare and drug development, and is actively pursuing a pipeline of therapeutics, diagnostics and orphan drug candidates with potential to provide a robust technology platform from which to build significant value.  For more information, visit the company’s website at www.qbiomed.com